Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

por Albertsson-Lindblad, Alexandra, Freiburghaus, Catja, Jerkeman, Mats, Ek, Sara
Publicado 2019

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

por Ekberg, Sara, Smedby, Karin E., Albertsson-Lindblad, Alexandra, Jerkeman, Mats, Weibull, Caroline E., Glimelius, Ingrid
Publicado 2022

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017

por Albertsson-Lindblad, Alexandra, Palsdottir, Thorgerdur, Smedby, Karin E., Weibull, Caroline E., Glimelius, Ingrid, Jerkeman, Mats
Publicado 2021

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project

por Jerkeman, Mats, Ekberg, Sara, Glimelius, Ingrid, Albertsson-Lindblad, Alexandra, Entrop, Joshua P., Ellin, Fredrik, Sonnevi, Kristina, Lewerin, Catharina, Brandefors, Lena, Smedby, Karin E.
Publicado 2023